相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Investigation of Mechanical, Material, and Compositional Determinants of Human Trabecular Bone Quality in Type 2 Diabetes
Praveer Sihota et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data
J. Ha et al.
OSTEOPOROSIS INTERNATIONAL (2021)
Controlled Formation of Carboxymethyllysine in Bone Matrix through Designed Glycation Reaction
Grazyna E. Sroga et al.
JBMR PLUS (2021)
The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: A systematic review and meta-analysis update
Tatiane Vilaca et al.
BONE (2020)
Bone Turnover Markers Do Not Predict Fracture Risk in Type 2 Diabetes
Nicola Napoli et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Sclerostin Regulation, Microarchitecture, and Advanced Glycation End-Products in the Bone of Elderly Women With Type 2 Diabetes
Alessandra Piccoli et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Pentosidine and carboxymethyl-lysine associate differently with prevalent osteoporotic vertebral fracture and various bone markers
Masaki Nakano et al.
SCIENTIFIC REPORTS (2020)
Individuals with type 2 diabetes mellitus show dimorphic and heterogeneous patterns of loss in femoral bone quality
Eva M. Woelfel et al.
BONE (2020)
Altered Tissue Composition, Microarchitecture, and Mechanical Performance in Cancellous Bone From Men With Type 2 Diabetes Mellitus
Heather B. Hunt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Vertebral Fracture Risk in Diabetic Elderly Men: The MrOS Study
Nicola Napoli et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Accumulation of carboxymethyl-lysine (CML) in human cortical bone
Corinne J. Thomas et al.
BONE (2018)
Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes
Lamya Karim et al.
BONE (2018)
Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men
Lydia S. Lamb et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Type 2 Diabetes Mellitus Is Associated With Better Bone Microarchitecture But Lower Bone Material Strength and Poorer Physical Function in Elderly Women: A Population-Based Study
Anna G. Nilsson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
A Mendelian Randomization Study of the Effect of Type-2 Diabetes and Glycemic Traits on Bone Mineral Density
Omar S. Ahmad et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Determinants of bone strength and quality in diabetes mellitus in humans
Joshua N. Farr et al.
BONE (2016)
Type 2 Diabetes and Aging: A Not so Sweet Scenario for Bone
R. Dhaliwal et al.
HORMONE AND METABOLIC RESEARCH (2016)
Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes
Jessica R. Furst et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Glycated Hemoglobin Level and Risk of Hip Fracture in Older People with Type 2 Diabetes: A Competing Risk Analysis of Taiwan Diabetes Cohort Study
Chia-Ing Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Serum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults
Richard D. Semba et al.
JOURNAL OF HYPERTENSION (2015)
Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
Kerstin Nowotny et al.
BIOMOLECULES (2015)
Nε-(Carboxymethyl) lysine- Receptor for Advanced Glycation End Product Axis Is a Key Modulator of Obesity-Induced Dysregulation of Adipokine Expression and Insulin Resistance
Katrien H. J. Gaens et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Hierarchical perspective of bone toughness - from molecules to fracture
Ani Ural et al.
INTERNATIONAL MATERIALS REVIEWS (2014)
Circulating Levels of Carboxy-Methyl-Lysine ( CML) Are Associated With Hip Fracture Risk: The Cardiovascular Health Study
Joshua I. Barzilay et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Bone quality assessment in type 2 diabetes mellitus
R. Dhaliwal et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Diabetes and Risk of Fracture-Related Hospitalization
Andrea L. C. Schneider et al.
DIABETES CARE (2013)
High Bone Mineral Density and Fracture Risk in Type 2 Diabetes as Skeletal Complications of Inadequate Glucose Control The Rotterdam Study
Ling Oei et al.
DIABETES CARE (2013)
Increased Cortical Porosity in Type 2 Diabetic Postmenopausal Women With Fragility Fractures
Janina M. Patsch et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Differences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous bone
L. Karim et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies
Lili Ma et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2012)
FRAX underestimates fracture risk in patients with diabetes
Lora M. Giangregorio et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Heterogeneous Glycation of Cancellous Bone and Its Association with Bone Quality and Fragility
Lamya Karim et al.
PLOS ONE (2012)
Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 Diabetes
Ann V. Schwartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Urinary Pentosidine Improves Risk Classification Using Fracture Risk Assessment Tools for Postmenopausal Women
Shiro Tanaka et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Effects of Preexisting Microdamage, Collagen Cross-Links, Degree of Mineralization, Age, and Architecture on Compressive Mechanical Properties of Elderly Human Vertebral Trabecular Bone
Helene Follet et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2011)
Does Accumulation of Advanced Glycation End Products Contribute to the Aging Phenotype?
Richard D. Semba et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2010)
Urinary levels of pentosidine and the risk of fracture in postmenopausal women: the OFELY study
E. Gineyts et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus
M. Saito et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Modification of collagen in vitro with respect to formation of N-epsilon-carboxymethyllysine
Hermann Ehrlich et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2009)
Pentosidine and Increased Fracture Risk in Older Adults with Type 2 Diabetes
Ann V. Schwartz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Combination of Obesity with Hyperglycemia is a Risk Factor for the Presence of Vertebral Fractures in Type 2 Diabetic Men
Ippei Kanazawa et al.
CALCIFIED TISSUE INTERNATIONAL (2008)
Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures
Masataka Shiraki et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2008)
Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes
Masahiro Yamamoto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle
Jacob M. Haus et al.
JOURNAL OF APPLIED PHYSIOLOGY (2007)
Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation
Ulrich Valcourt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Renal function and risk of hip and vertebral fractures in older women
Kristine E. Ensrud et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Thiazolidinedione use and bone loss in older diabetic adults
Ann V. Schwartz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Risk factors for fragility fracture in middle age.: A prospective population-based study of 33,000 men and women
A. H. Holmberg et al.
OSTEOPOROSIS INTERNATIONAL (2006)
In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml/min is a risk factor for falls and fractures
L Dukas et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone
S Kume et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk
P Vestergaard et al.
DIABETOLOGIA (2005)
Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients
XH Zhang et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2005)
Effect of advanced glycation end-products on gene expression and synthesis of TNF-α and endothelial nitric oxide synthase by endothelial cells
G Rashid et al.
KIDNEY INTERNATIONAL (2004)
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
G Basta et al.
CARDIOVASCULAR RESEARCH (2004)
Elevated serum levels of Nε-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema
BO Boehm et al.
DIABETOLOGIA (2004)
Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes
K Hirata et al.
ENDOCRINE JOURNAL (2004)
Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix
AD McCarthy et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: Cross-sectional results from the Canadian Multicentre Osteoporosis Study
DA Hanley et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Advanced glycation end products activate endothelium through signal-transduction receptor RAGE - A mechanism for amplification of inflammatory responses
G Basta et al.
CIRCULATION (2002)
Diabetes and risk of fracture - The Blue Mountains Eye Study
RQ Ivers et al.
DIABETES CARE (2001)
分享论文
